“Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review” (2025) Annals of Gastroenterology and Digestive Disorders, 8(1), pp. 5–9. doi:10.5281/zenodo.22202865.